Alesse tablets are not classified as a controlled substance, so they can be carried in hand luggage or checked baggage. It is advisable to keep the original packaging and a copy of the prescription, especially when traveling outside the UK, to demonstrate legitimate medical use if requested.
Combined oral contraceptives do not contain substances that trigger standard workplace drug-testing panels. However, hormonal levels are not screened in routine occupational testing.
Alesse offers two dose strengths: a lower-dose formulation (0.15 mg/0.03 mg) and a slightly higher dose (0.25 mg/0.05 mg). Compared with many other COCs, these doses fall within the typical range used for effective contraception while aiming to minimise side effects.
The 0.15 mg/0.03 mg tablets are round, white, and bear the imprint “A 01”. The 0.25 mg/0.05 mg tablets are round, orange-blue, and carry the imprint “A 02”. Imprints may vary slightly between manufacturers.
When a pill is missed by more than 12 hours, use a barrier method (e.g., condoms) for the next seven days while the hormonal protection re-establishes. If the missed pill occurs during the first week, consider using backup for 48 hours.
Some users report mood changes, such as irritability or low mood, particularly during the initial months. Evidence linking COCs to long-term mood disorders is mixed; any persistent emotional symptoms should be discussed with a healthcare professional.
St John’s wort is a known enzyme inducer that can lower the effectiveness of combined oral contraceptives. Concurrent use is discouraged unless a reliable non-hormonal backup method is employed.
No. Alesse prevents pregnancy but does not provide protection against STIs. Barrier methods such as condoms should be used to reduce STI risk.
Each pack contains 21 active tablets plus a 7-day placebo interval, covering a 28-day cycle. Prescription renewals are usually arranged monthly, but many UK prescribers provide a 3-month supply for stable users.
Fertility often returns quickly after discontinuation, with many women experiencing a natural period within 4-6 weeks. Some may notice temporary irregularities or a short delay, which typically resolve without intervention.
Alesse is a brand-name combined oral contraceptive (COC) that contains the synthetic hormones levonorgestrel (a progestogen) and ethinyl estradiol (an estrogen). It is supplied as a round-shaped oral pill in two strength options: 0.15 mg levonorgestrel / 0.03 mg ethinyl estradiol and 0.25 mg levonorgestrel / 0.05 mg ethinyl estradiol. In the United Kingdom Alesse is a prescription-only medicine (POM) regulated by the Medicines and Healthcare products Regulatory Agency (MHRA).
Alesse prevents pregnancy by delivering a steady dose of synthetic estrogen and progestogen that suppress ovulation. The estrogen component stabilises the endometrial lining, while the progestogen:
These effects begin within the first few days of pill intake and are maintained as long as the regimen is followed. The hormonal levels in Alesse are designed to mimic the natural menstrual cycle, allowing a predictable withdrawal bleed during the placebo week.
Alesse is licensed in the UK for the following indications:
It is not approved for treating acne, hormonal imbalances unrelated to contraception, or any non-reproductive conditions.
Alesse is suitable for most healthy women who:
If any of the above conditions apply, a healthcare professional should evaluate alternative contraception methods.
These effects are usually transient and resolve within a few cycles. If they persist or significantly affect quality of life, professional advice should be sought.
Any sudden chest pain, shortness of breath, severe leg pain, or neurological symptoms require immediate medical attention.
Major interactions (may reduce contraceptive effectiveness)
Moderate interactions (require monitoring)
Mechanism: Induction of hepatic enzymes accelerates hormone metabolism, lowering circulating levels. Women taking interacting drugs should consider backup non-hormonal contraception (e.g., condoms) and discuss alternative hormonal methods with their prescriber.
Patients should always disclose all prescribed medicines, over-the-counter products, and herbal supplements to their healthcare provider.
Alesse is taken once daily for 21 consecutive days, followed by a 7-day pill-free interval during which a withdrawal bleed occurs. The packaging includes 21 active tablets (either 0.15/0.03 mg or 0.25/0.05 mg) and a set of inert placebo pills (or a blank week). The regimen can be started:
Signs of overdose may include prolonged nausea, vomiting, or heavy uterine bleeding. Management is primarily supportive: induce emesis only if within a very short time frame and under medical supervision, monitor vital signs, and treat symptomatic bleeding. No specific antidote exists.
Alesse may be stopped at the end of a pack or anytime with medical guidance. Women wishing to become pregnant are advised to allow a “wash-out” period of 1-2 months for ovulatory cycles to return, though fertility often resumes quickly after cessation.
Regular follow-up ensures continued suitability of the contraceptive method and allows early detection of adverse events.
This article provides educational information about Alesse and is not a substitute for professional medical advice. Treatment decisions, including the choice of contraception, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
